Dave emails to add something I missed in my column this week discussing the recent weakness in BioDelivery Sciences (BDSI - Get Report) and its cancer pain drug Onsolis.
Last, I was pleasantly surprised to hear from "Big % Gains Ltd." last week after my discussion of Cell Therapeutics' (CTIC) recent fund-raising effort. "Today you were fair and balanced. That's all I ask." A Cell Therapeutics' investor is happy with me? We live in strange times, indeed! -- Reported by Adam Feuerstein in Boston